High treatment success among individuals with rifampicin-resistant tuberculosis in Botswana: A retrospective cohort study
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
The study reports on tuberculosis (TB) treatment outcomes among individuals diagnosed with rifampicin-resistant TB (RR-TB) and assesses predictors associated with treatment outcomes.
Methods
We conducted a retrospective study to analyse treatment outcomes of 162 individuals with RR-TB from 2016 to 2023. Treatment outcome proportions were estimated using the binomial exact method with 95% confidence intervals (CI). Predictors of treatment outcomes were assessed using logistic regression models.
Results
Of the 162 individuals, 102 (62.7%) were male with a median age of 39 (interquartile range (IQR): 29-50). Most individuals, 78 (48.1%), were from the Greater Gaborone health district, and 88 (54.3%) were people living with HIV (PLWH). Among these individuals, 137 (84.6%, 95% CI [78.2, 89.7]) were successfully treated. Males had higher odds of unfavourable treatment outcomes compared to females (OR = 1.70; 95% CI [0.73, 3.98]). Among those cured, a slightly higher proportion was observed among PLWH (71.8%, 95% CI [62.1, 80.3]) compared to people not living with HIV (PNLWH) (69.2%, 95% CI [58.7, 78.5]). However, the mortality rate was higher in PLWH (10.7%; 95% CI [5.5, 18.3]) compared to PNLWH (6.6%; 95% CI [2.5, 13.8]). Those with a history of TB treatment had 1.03 odds of unfavourable treatment outcomes (95% CI [0.40, 2.73]); however, this association was not statistically significant.
Conclusion
Our study shows a high success rate of treatment among individuals with RR- TB, with no significant difference based on sex, TB treatment history, or HIV status. Higher mortality among PLWH highlights the need for targeted interventions among high-risk groups.
